{"database": "lobbying", "table": "lobbying_activities", "rows": [[1959218, "d6c9e1ed-257e-4284-ac7b-d75f1ca1c9e1", "Q1", "FAEGRE BAKER DANIELS CONSULTING", 34158, "MYRIAD GENETIC LABORATORIES, INC.", 2017, "first_quarter", "MED", "FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and FDA.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2017-04-19T10:53:15.723000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1959218"], "units": {}, "query_ms": 35.03091196762398, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}